Evaluating coronary re-engagement after TAVR with a Navitor valve

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the feasibility of coronary re-engagement following the implantation of a Navitor valve during Transcatheter Aortic Valve Replacement (TAVR) procedures. It aims to determine whether a random implantation technique can maintain effective access to coronary arteries, which is crucial for patients with pre-existing coronary artery disease. The study will assess the outcomes of patients with severe symptomatic aortic stenosis who undergo TAVR, focusing on the procedural complexity and the potential for unplanned coronary interventions. By comparing aligned versus random valve placements, the study seeks to provide insights into optimizing TAVR procedures for better patient outcomes.

Why it matters

Who can join: the full rules

Patients to be included in this registry should have all the following criteria:

1\. Severe, symptomatic aortic stenosis with an indication to TAVI

Exclusion criteria and definition

Patients excluded in this registry should have all the following criteria:

1. Valve in Valve procedure
2. Hemodynamical instability
3. TAVR performed from other access (not femoral)
4. No-CT Planned TAVR
5. TAVR performed with Chimney Technique

Where it's running

• ASST GOM Niguarda
  Milan, Lombardy, Italy Recruiting

Study contacts

• Study coordinator: Giuseooe Esposito, MD
• Email: giuseppe.esposito@yahoo.com
• Phone: +393278393131

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluation of the Point-Guard device during heart valve replacement

  This study is testing a new device called Point-Guard to see if it can help prevent brain problems during heart valve replacement surgery.

  Recruiting Transverse Medical, Inc. · Clayton, Victoria · NCT06962371

• Evaluating the SAPIEN 3 Ultra RESILIA Valve for Aortic Stenosis

  This study tests how well the new SAPIEN 3 Ultra RESILIA valve works for people with severe aortic stenosis who are getting a heart valve replacement, by checking its performance over the next 10 years.

  Recruiting Institut universitaire de cardiologie et de pneumologie de Québec, University Laval · Québec, Quebec · NCT06420830

• Assessing ischemic and bleeding risks after TAVR

  This study looks at the risks of bleeding and heart problems in patients getting a new heart valve through TAVR to see how to best tailor their blood-thinning treatment.

  Recruiting at 12 sites Niguarda Hospital · Aalst and 11 other locations · NCT06000943

• Transcatheter Aortic Valve Replacement Registry for Outcomes and Quality Monitoring

  This registry collects information from hospitals about patients undergoing TAVR to see how care and outcomes compare to guidelines and nationwide data.

  Recruiting American College of Cardiology · Washington D.C., District of Columbia · NCT07908355

• SYMmetric Valve expansion to reduce hypoattenuated leaflet thickening after balloon-expandable TAVI

  This trial tests whether the Double-TAP post-dilatation strategy can reduce HALT and improve valve function in patients 70 or older undergoing balloon-expandable TAVI.

  Recruiting Erasmus Medical Center · Düsseldorf and 4 other locations · NCT07872020

• Vericiguat to slow calcific aortic valve narrowing

  This trial tests whether vericiguat can slow the progression of mild-to-moderate calcific aortic valve stenosis compared with placebo.

  Recruiting Phase 2 West China Hospital · Chengdu, Sichuan · NCT07715279

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.